Back to Search
Start Over
Romiplostim in Low/INT-1-Risk MDS Results in Reduced Bleeding without Impacting Leukemic Progression: Final Results from a Randomized, Double-Blind, Placebo-Controlled Study
- Source :
- Leukemia Research. 55:S12-S14
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- Cancer Research
medicine.medical_specialty
Romiplostim
business.industry
INT
Placebo-controlled study
Hematology
030204 cardiovascular system & hematology
Surgery
Double blind
03 medical and health sciences
0302 clinical medicine
Oncology
Internal medicine
Medicine
030212 general & internal medicine
business
medicine.drug
Subjects
Details
- ISSN :
- 01452126
- Volume :
- 55
- Database :
- OpenAIRE
- Journal :
- Leukemia Research
- Accession number :
- edsair.doi...........12de8c83d3b7eb46a76caf69028d9b1c